VAERS Explorer
Back to explore

Report #2824758

Received Feb 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
CA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.2——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

received the second dose of GARDASIL-9 a month late; No additional AE; This spontaneous report was received from an adult patient female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (dose, strength, lot #, expiry date, and route of administration were not provided), which was month late (inappropriate schedule of product administration) and wanted to know whether she should restart the dose or continue with the schedule. No additional adverse event (AE) was reported.